Pages that link to "Q33700990"
Jump to navigation
Jump to search
The following pages link to Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repression (Q33700990):
Displaying 16 items.
- Challenges and opportunities for non-antibody scaffold drugs (Q26781607) (← links)
- Membrane domain formation-a key factor for targeted intracellular drug delivery (Q26998461) (← links)
- Π-Clamp-mediated cysteine conjugation (Q28833204) (← links)
- A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA. (Q33701022) (← links)
- Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity (Q34212771) (← links)
- Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptides. (Q34662933) (← links)
- High-throughput epitope binning assays on label-free array-based biosensors can yield exquisite epitope discrimination that facilitates the selection of monoclonal antibodies with functional activity (Q35126754) (← links)
- Engineering pH responsive fibronectin domains for biomedical applications (Q35770463) (← links)
- Antibody-mediated neutralization of perfringolysin o for intracellular protein delivery (Q36926959) (← links)
- A Modeling and Experimental Investigation of the Effects of Antigen Density, Binding Affinity, and Antigen Expression Ratio on Bispecific Antibody Binding to Cell Surface Targets (Q36987701) (← links)
- Targeting the ERBB family in cancer: couples therapy (Q38129286) (← links)
- Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment. (Q39005581) (← links)
- Understanding the role of cross-arm binding efficiency in the activity of monoclonal and multispecific therapeutic antibodies (Q39122846) (← links)
- Targeting autophagy to modulate cell survival: a comparative analysis in cancer, normal and embryonic cells (Q41912427) (← links)
- Bispecific applications of non-immunoglobulin scaffold binders (Q57059568) (← links)
- A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity (Q99574593) (← links)